-
, and brain. Identifying new mechanisms that drive therapeutic resistance in metastatic disease. To tackle these questions, we use cutting-edge technologies, including spatial transcriptomics, single-cell
-
fibrosis, in vitro and in vivo testing therapeutic candidates, scRNAseq, spatial transcriptomics, confocal and electron microscopy imaging, flow cytometry, and standard biochemical/molecular approaches. Our
-
, computational musicology and music theory, music cognition, spatial/immersive audio, generative music systems, human-computer interaction, machine improvisation, musical robotics, and/or new interfaces
-
scope includes primary immune cell isolation and manipulation, high-dimensional flow cytometry, multiplex immune profiling, spatial and single-cell transcriptomics, and functional assays to evaluate
-
. Duties will include conducting laboratory work centered around mass spectrometry method development for Spatial SILAC (stable isotope labeling by amino acids in cell culture); leading manuscript
-
-cell transcriptomic, and spatial transcriptomic analysis for brain metastasis research. Utilizing hESC/iPSC derived human cerebral organoid for in vitro 3D models to examine the microenvironment of brain
-
cut lung slices, transgenic rodent models, preclinical models of lung fibrosis, in vitro and in vivo testing therapeutic candidates, scRNAseq, spatial transcriptomics, confocal and electron microscopy
-
-based microarrays, immunohistocheistry, spatial transcriptomics and molecular analysis. The candidate is expected to be able to summarize data for inclusion in grant proposals and manuscripts; prepare
-
: the economics of science and innovation, education, consumer or household finance, urban and regional economics, labor economics, or spatial econometrics. Desired Qualifications: The ideal candidate will bring